Taken together, it is clear that non-responsiveness to an SSRI or to a TCA (nortriptyline) can likely be predicted by determining the expression level of combinations of important immune genes (IL1β, MIF, TNF, and CD3) in preparations of circulating leukocytes of patients with MDD. The gene discussed is TNF; the disease is major depressive disorder.